T36.1X2 Poisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm

Name of the Condition

• Poisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm

Summary

This condition involves intentional self-harm resulting from exposure to cephalosporins or other beta-lactam antibiotics. It includes cases where deliberate ingestion or administration leads to harmful effects, requiring clinical assessment and documentation of the event’s circumstances. Documentation should specify the antibiotic type, intentional nature, and encounter details.

Causes

Intentional self-harm may result from deliberate overdose, self-administration, or misuse of cephalosporins or other beta-lactam antibiotics. Underlying factors such as psychiatric conditions, substance use, or emotional distress may contribute. Allergic reactions or idiosyncratic responses may exacerbate adverse outcomes.

Risk Factors

• Prior history of beta-lactam allergies or sensitivities.
• Psychiatric conditions or emotional distress.
• Substance use disorders.
• Access to prescription medications.
• Prior self-harm behaviors or suicidal ideation.

Symptoms

• Gastrointestinal: Nausea, vomiting, diarrhea, abdominal pain.
• Allergic: Rash, urticaria, anaphylaxis.
• Systemic: Fever, hypotension, organ dysfunction (e.g., nephrotoxicity).
• Neurological: Dizziness, confusion, or seizures in severe cases.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, patient history, and confirmation of intentional exposure. Laboratory tests may assess drug levels, organ function, or allergic markers. Documentation must clearly indicate the intentional nature of the event and the specific beta-lactam antibiotic involved.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing underlying causes. Interventions may include decontamination, supportive care, and psychiatric evaluation. Specific therapies depend on the severity of poisoning and patient response.

Prognosis and Follow-Up

Prognosis varies based on the amount ingested, time to treatment, and patient factors. Follow-up includes monitoring for complications, psychiatric assessment, and prevention strategies. Long-term outcomes depend on timely intervention and addressing underlying risks.

Complications

Potential complications include organ damage (e.g., renal or hepatic), severe allergic reactions, or neurological effects. Delayed treatment may increase the risk of adverse outcomes.

Lifestyle & Prevention

Prevention involves secure medication storage, patient education on safe use, and addressing mental health concerns. Support systems and crisis resources may reduce intentional self-harm risks.

When to Seek Professional Help

Seek immediate medical attention if intentional exposure to beta-lactam antibiotics occurs, or if symptoms such as severe allergic reactions, organ dysfunction, or altered mental status develop.

Tips for Medical Coders

Document the specific beta-lactam antibiotic, the intentional nature of the event, and encounter details. Ensure clarity on self-harm intent and any contributing factors to support accurate coding.